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ABSTRACT 
Among the palette of fluorescent organic molecules described up to now, coumarins are ideal candidates 
for developing cellular and molecular imaging tools due to their high cell permeability and minimal 
perturbation to the living system. However, blue to cyan fluorescence emission usually difficult in vivo 
applications due to the inherent toxicity and poor tissue penetration of short visible light wavelengths. 
Here we introduce a new family of coumarin-based fluorophores, nicknamed COUPY, with promising 
photophysical properties, including emission in the far-red/NIR region, large Stokes’ shifts, high 
photostability, and excellent brightness. COUPY fluorophores were efficiently synthesized in only three 
linear synthetic steps from commercially available precursors, the N-alkylation of a pyridine moiety being 
the key step at the end of the synthetic route since it allows to tune the photophysical properties of the 
resulting dye. Owing to their low molecular weight, COUPY dyes show excellent cell permeability and 
accumulate selectively in nucleoli and/or mitochondria of HeLa cells, being their far-red/NIR fluorescence 
emission easily detected at a concentration as low as 0.5 M after incubation for only 20 min. We 
anticipate that these coumarin scaffolds will open the way to the development of novel coumarin-based 
far-red to NIR-emitting fluorophores with potential applications for organelle imaging and biomolecule 
labelling. 
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INTRODUCTION 
Fluorophores based on organic molecules are powerful tools in modern cellular and molecular imaging 
techniques as well as for the in vivo detection and/or quantification of biologically relevant species.
1
 
Among them, far-red and near-infrared (NIR) fluorophores are particularly interesting since emission at 
longer wavelengths exhibits several appealing features such as deep tissue penetration, minimal 
autofluorescence interference and low light scattering, while minimizes photodamage to living cells 
compared with UV and blue light.
2
 Despite the large number of far-red/NIR fluorescent dyes described up 
to now, most of them are far from being ideal due to sub-optimal photophysical parameters (e.g. small 
Stokes shifts and poor photostability) and physico-chemical properties (low aqueous solubility, 
undesirable aggregation)
3
 due to their large size and structural complexity, the latter being a consequence 
of the necessity of extending -conjugation to red-shift absorption and emission. Most commercially 
available far-red or NIR fluorophores are derived from cyanines,
4
 which are also highly polar, making 
them cell impermeable and not completely suitable for use in live cells. Consequently, it is urgent to 
develop new fluorophores based on low molecular-weight scaffolds operating in the optical window of the 
tissues with high cell permeability and minimal perturbation to the living system.
5
 Ideally, such small 
scaffolds should be amenable to smart structural modifications to easily tune their absorption/emission 
properties on demand, preferably at the late synthetic stages,
6
 as well as for facilitating conjugation to 
biomolecules such as lipids, peptides, proteins, oligonucleotides or antibodies.  
Among the palette of fluorescent organic molecules,
1,3a
 coumarin scaffolds are ideal candidates for this 
purpose owing to their good cell membrane permeability and well-stablished photophysical properties. 
The fluorescence emission of the basic coumarin scaffolds (e.g. compound 1 in Scheme 1, usually referred 
to as Coumarin 1) can be shifted from blue to cyan by incorporating electron-donating groups at position 7 
of the coumarin skeleton (e.g. N,N-dialkylamino or hydroxy/alkoxy) that partner with the electron-
withdrawing lactone moiety to create a push-pull effect. Based on this premise, great efforts have been 
devoted to red-shift the emission of coumarins by introducing additional electron-withdrawing groups 
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(EWG) at positions 3 and/or 4 (CN, CF3, carboxyl), by extending the conjugation system through 
position 3 with methine, carbonyl o heteroaryl linkages,
7
 or by fusion of aromatic cycles,
8
 including other 
fluorescent scaffolds such as rhodamine
9
 or BODIPY.
7b,10
  
Despite huge synthetic efforts dedicated to the coumarin scaffold, little work has been devoted to 
modifying the lactone function. Thionation of the carbonyl group (e.g. compound 2 in Scheme 1) is 
known to cause significant red-shift, leading to blue absorption (max 470 nm) and green light emission 
(em 550 nm) in the 7-N,N-diethylamino series.
11
 Similarly, extending the conjugation of the system at 
position 2 via the incorporation of a dicyanomethylene group (e.g. compound 3 in Scheme 1) has been 
reported to induce similar bathochromic effects both in absorption and in emission in several systems,
12
 
including dicyanocoumarin-caged morpholino oligonucleotides
12c
 and RGD-containing peptides.
12d
 Very 
recently, we have reported for the first time the synthesis of coumarin derivatives in which one cyano 
group in coumarin 3 was replaced by a phenyl ring containing EWGs at ortho and para positions to 
increase the push-pull character of the chromophore (e.g. compound 4 in Scheme 1).
13
 Although such 
modifications red-shifted absorption into the green to red region and allowed to obtain new caging groups 
photoremovable with visible light, the incorporation of several strong EWGs such as nitro was found to 
have a negative effect on the fluorescence emission of the compounds.
13
  
 
Scheme 1. Rational design of the new coumarin-based fluorophores synthesized in this work. 
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With the aim of further red-shift absorption and emission of the coumarin scaffold while keeping a low-
molecular weight, we focused on replacing one cyano group in the dicyanomethylenecoumarin 3 by 
pyridine (Scheme 1). We reasoned that this modification could increase the -conjugation and the push-
pull character of the chromophore, which would result in a large bathochromic shift in absorption and 
emission bands. The electron-deficient pyridine heterocycle offers many other attractive features, such as 
the possibility of tuning its electronic properties through the incorporation of EWG substituents as well as 
N-alkylation. The latter is an important advantage since the resulting positive charge on the nitrogen atom 
would lead to an increased electron-withdrawing effect and, consequently, to a large intramolecular 
charge-transfer effect along the coumarin skeleton. Based on this rational design, here we introduce a new 
family of coumarin-based fluorophores, nicknamed COUPY, which shows promising photophysical 
properties, including large Stokes’ shifts, large photostability, brightness and emission in the far-red/NIR 
region. Importantly, their photophysical properties were easily tuned by selecting the appropriate 
combination of the N-alkylating group at the pyridine moiety (CH3 or CH2CF3) and the substituent at 
position 4 (CH3 or CF3), while keeping a low molecular weight (M.W. 340-440) and rapid access in only 
three linear synthetic steps from cheap commercially available precursors. Moreover, excellent cell 
permeability was found in HeLa cells, where the compounds accumulated selectively in nucleoli and/or 
mitochondria. 
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RESULTS AND DISCUSSION 
Design, synthesis and characterization of COUPY scaffolds 
The synthesis of the new fluorophores was designed from commercially available Coumarin 1 (1) 
(Scheme 2). We also selected Coumarin 152 (5) because the incorporation of strong EWGs such as CF3 at 
the position 4 of the coumarin skeleton is known to increase the photostability of the dye when compared 
with the unsubstituted derivative,
14
 and to induce a pronounced red-shift of the absorption and emission 
bands by enhancing its “push-pull” character.7bc,15 This modification has been applied in a coumarin-based 
commercially available dye (AlexaFluor 430) and in the xanthene skeleton for developing deep-red and 
NIR dyes.
9b,16
 Since we and others have demonstrated the utility of thiocoumarin derivatives to introduce 
the dicyanomethylene functionality within the coumarin skeleton,
12bcde
 we first synthesized thiocoumarins 
2
13
 and 6 by reaction with Lawesson’s reagent (LW, Scheme 2). To our delight, condensation with 4-
pyridylacetonitrile in the presence of a strong base followed by treatment with silver nitrate afforded 
coumarins 7 and 8 in excellent yields after silica column chromatography (89 % and 84 %, respectively). 
Full characterization was carried out by high resolution ESI mass spectrometry and NMR (
1
H, 
13
C and 
19
F) 
and the purity was assessed by reversed-phase HPLC-MS (Figure S1), revealing a single peak in both 
cases. 
 
Scheme 2. Synthesis of coumarin fluorophores 9-12. 
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Interestingly, the 
1
H NMR spectrum of coumarin 7 showed the presence of two sets of proton signals in 
CDCl3 and in DMSO-d6 in an  90:10 ratio (see Figure 1), and the same duplicity was found in the 
13
C 
NMR spectra. Full assignment of the 
1
H NMR spectrum by using 2D COSY and NOESY experiments 
(Figures 1 and S3-S4) confirmed the presence of two species in slow equilibrium in solution on the 
chemical shift time scale. As shown in Figure 1B, the presence of chemical exchange cross-peaks between 
the resonances of the two species in the 2D NOESY spectrum accounts for the existence of E and Z 
interconverting rotamers around the exocyclic C=C bond with an exchange rate (kex) of approximately <10 
s
-1
. It should be mentioned that noticeable exchange cross-peaks were only observed in DMSO-d6 and not 
in CDCl3. Further evidence of the dynamic interconversion of the two species was provided by 1D-
selective chemical exchange experiments (Figure 1C).
17
 The existence of rotamers instead of 
diastereomers can be attributed to the strong push-pull character of the compounds: the exocyclic C=C 
bond connecting the C-2 of the coumarin moiety and the C-4 of the pyridine cannot be considered a pure 
double bond but a double bond with partial single bond character due to -delocalization. The presence of 
diagnostic NOE cross-peaks such as the one between H3 proton of the coumarin in the minor rotamer and 
the meta protons of the pyridine (Figure 1) allowed to conclude that the E rotamer was the one preferred 
(as usually drawn in the manuscript). A similar behavior was found for the 4-trifluoromethylcoumarin 
analogue (8), in which an  93:7 mixture of the two rotamers was identified in solution by NMR (Figures 
S5-S6). Again, 
1
H-
1
H NOESY experiments allowed to conclude that the E rotamer was the major species 
in solution. 
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Figure 1. A) Structure of E and Z rotamers of coumarin 7 with some diagnostic NOE cross-peaks 
indicated. B) Expansion of the 2D NOESY spectrum (tm = 500 ms, 25ºC) of 7 in DMSO-d6 showing 
exchange cross-peaks between rotamer resonances of the same sign as the diagonal. C) 1D gradient NOE 
spectrum of coumarin 7 with an initial selective pulse at 7.71 ppm (top) or at 2.37 ppm (bottom) conduces 
to new peaks of the same phase at 7.41 ppm or at 2.39 ppm, respectively, implying chemical exchange 
and, for instance, the existence of rotamers. 
 
Having stablished by NMR the existence of rotamers in solution for the two coumarin scaffolds, we 
decided to get some more insights on these experimental observations from a theoretical point of view. 
DFT calculations were carried out with the Gaussian09 (G09) software package (see Figures S11-S16 and 
Tables S1-S5 in the Supporting Information). As shown in Figure 2, the core of the coumarin scaffold 7 is 
essentially planar in the optimized structures of the two rotamers, being the pyridine moiety slightly 
twisted. The C-C and C-N bond lengths determined by DFT calculations confirmed the strong electronic 
9 
 
delocalization along the -conjugated system, from the electron-donating NEt2 group to the pyridine and 
nitrile. Notably, the value of the exocyclic C=C bond length (1.40 Å) is the intermediate between a single 
(1.45 Å) and double (1.33 Å) Csp
2
-Csp
2
 bond (Table S3). The calculated rotational energy barrier (19.6 
kcal/mol, Figure 2C) enables interconversion under normal conditions, and the calculated probability of 
obtaining E and Z rotamers was approximately 84% and 16%, respectively, which is in good agreement 
with the experimental ratio determined by NMR. Moreover, a good correlation between the charges of the 
atoms calculated using the electrostatic potential (ESP) fitting method (Table S4 and Figure S13) and the 
expected electronic delocalization of the system was found.  
Figure 2. DFT optimized structures of rotamers E (A) and Z (B) of coumarin 7, and energy profile 
resulting from rotating the  dihedral angle, from the Z rotamer to the E rotamer (C). 
Synthesis and photophysical characterization of COUPY fluorophores 
To our delight, analysis by UV-HPLC-MS of coumarin derivatives 7 and 8 (Figure S1) revealed a strong 
bathochromic shift (63 and 85 nm, respectively) of their absorption maximum compared with that of the 
parent dicyanocoumarin 3 (max = 478 nm in 3 vs max = 541 nm in 7 and max = 563 nm in 8) and even 
with respect coumarin 4 (max = 499 nm).
13
 This red-shift can be attributed to the increased push-pull 
character of the conjugated π-electron system of the chromophore due to the replacement of the nitrile 
group in 3 or the p-nitrophenyl in 4 by pyridine, which was assumed to be protonated during HPLC 
analysis under acidic conditions (0.1% trifluoroacetic acid). Such encouraging results led us to synthesize 
N-alkylated pyridinium analogues to obtain pH-independent fluorophores based on the two COUPY 
CA B
10 
 
scaffolds. As shown in Scheme 2, reaction of 7 with methyl trifluoromethanesulfonate afforded N-
methylpyridinium-coumarin derivative 9 as a purple solid with excellent yield and purity after a simple 
precipitation without the need of further purification. Using this simple method, we readily prepared 
coumarin 10 by using the commercially available 2,2,2-trifluoroethyl trifluoromethanesulfonate as 
alkylating reagent with the aim of causing an additional red-shift of the maximum absorption because of 
the strong electron-withdrawing character of the CF3 group. Following the optimized procedures, we 
synthesized the 4-trifluoromethyl analogues 11 and 12 from coumarin scaffold 8 (Scheme 2). The four 
new coumarin derivatives were isolated as purple (9-11) and dark blue solids (12) and fully characterized 
by HR ESI-MS and 1D (
1
H, 
13
C and 
19
F) and 2D NMR, and their purity was assessed by HPLC analysis 
(Figure S2). It is worth noting that the E rotamer was the major species in solution for coumarin 
derivatives 9, 10 and 12 as inferred by 2D NOESY experiments (Figures S7-S10), while 8% of rotamer Z 
was identified in solution for coumarin 11.  
Having at hand four new coumarin derivatives, we investigated their photophysical properties (absorption 
and emission spectra, molar absorption coefficients (), fluorescence quantum yields (F) and 
fluorescence life-time (F)) in several solvents of different polarity and viscosity (H2O, phosphate buffer 
saline (PBS), methanol (MeOH), glycerol, acetonitrile (ACN), dichloromethane (DCM) and toluene). The 
UV-Vis absorption and emission spectra are shown in Figure 3 and Figures S17-S18 and their 
photophysical properties are summarized in Tables 1 and S6. All the compounds showed an intense 
absorption band in the yellow-red part of the visible spectrum, with absorption maxima ranging from 569 
nm (9, DCM) to 621 nm (12, DCM), which provided intense coloured solutions (Figure 3). As expected, 
from 7-8 coumarin derivatives, replacement of the CH3 group at position 4 of the coumarin skeleton by the 
strong electron-withdrawing CF3 caused a significant red-shift (from 21 to 33 nm, depending on the 
solvent) in the absorption maximum wavelength. A similar effect was observed when comparing N-
methylated compounds with the corresponding N-trifluoroethylated analogues, as exemplified by the far-
red absorption of the compound containing two CF3 groups (12). The position of the maxima for the N-
methylated compounds were not modified by changing the pH beyond a small shift (Figure S19). By 
11 
 
contrast, the spectroscopic properties of the non-methylated compounds, e.g. 7, were strongly influenced 
by the pH of the media, which correlates well with the protonation state of the pyridine moiety. However, 
the striking observation was made that all the compounds showed negative solvatochromism, i.e., the 
absorption maxima shifted to the blue when increasing solvent polarity (e.g. for 9: abs = 543 nm in H2O 
and 569 nm in DCM) which sets them apart from conventional coumarin derivatives.
18
 This suggests that 
COUPY dyes have a smaller dipole moment in the excited state than in the ground state, in agreement 
with the computational results (Figure S13). For 9-12, the difference between the ground and excited state 
dipole moments is in the range -4.8 to -6.1 D (Table S6 and Figure S21).
19 
The molar absorption 
coefficients () were also influenced by the polarity of the solvent, showing hyperchromism in less polar 
solvents, and by the nature of the R
1
 substituent: 4-CF3 coumarins exhibited smaller values than the 4-
CH3 analogues.  
 
 
12 
 
 
Figure 3. Top: Comparison of the normalized absorption (solid lines) and fluorescence (dotted lines) 
spectra of COUPY dyes (compounds 9-12) in DCM (black lines) and in H2O (red lines). Bottom: 
Photographic images of coumarin derivatives 9-12 (5 M) in DCM under day light (left) and in the dark 
(right) upon irradiation with green light laser (532 nm). 
Very interestingly, coumarin derivatives 9-12 showed emission in the far red to NIR region (Figures 3 and 
S18), with emission maximum ranging from 609 nm (9, ACN) to 689 nm (12, ACN), which again 
demonstrated that the incorporation of CF3 groups into the coumarin skeleton was highly positive for red-
shifting the emission. In contrast with absorption maxima shift, the effect of solvent polarity on the 
compounds’ emission maxima was minimal in all the solvents studied (Tables 1 and S6). This indicates 
that the states initially populated by light absorption and those responsible for emission are different. As a 
result, the Stokes’ shifts of all the dyes in polar solvents were considerably larger than those of classical 7-
dialkylaminocoumarins, particularly those of the 4-CF3 derivatives (e.g. 62 nm for 9 vs 95 nm for 11 in 
H2O).  
Coumarins 9 and 10 exhibited excellent F in less-polar solvents DCM and toluene (0.31-0.70), while its 
F decreased in polar protic and non-protic polar solvents (0.10-0.18). Fluorescence quenching in polar 
solvents might be a consequence of the formation of a twisted intramolecular charge transfer (TICT) 
excited state, which should be more stable in polar media.
20,21
 TICT states are known to relax rapidly by 
non-radiative decay pathways, thereby decreasing the fluorescence yields in polar media. For 9-12, this 
hypothesis was supported by the observation of F enhancement in glycerol compared to methanol (Table 
S6). These two solvents have similar polarity and only the high viscosity of glycerol could prevent the 
twisting out of the 7-alkylamino group out of the coumarin plane, thereby reducing the formation of the 
TICT and enhancing the fluorescence yield.
22
 Further confirmation was obtained by time-resolved 
fluorescence spectroscopy, where the fluorescence lifetime was found to be longer in less-polar and 
viscous solvents, indicating that the competing deactivation channel has been arrested (Figure S20). 
Despite its decrease in polar solvents, it is worth noting that F of dyes 9 and 10 are still higher (e.g 
13 
 
F=0.15 for 9 in H2O) than those of the unmodified coumarin 1 (e.g. F=0.058 in H2O)
21c
 or even of the 
parent dicyanocoumarin derivative 3 (e.g. F=0.05 for 3
13
 vs F=0.15 for 9 in MeOH). Thus the 
replacement of one cyano group in 3 by N-alkylpyridinium not only red-shifts its absorption and emission 
but it also improves the photophysical parameters relevant for cell imaging purposes, such as Stokes’ shift, 
F and brightness.  
Table 1. Photophysical data of the coumarin derivatives 9-12 in different solvents. 
 
R / R
1 
compd R
2 
Solvent 
abs 
(nm) 

(mM
-1
cm
-1
) 
em 
(nm) 
Stokes 
Shift 
(nm) 
F 
F 
(ns) 
R = Et 
 
R
1
 = CH3 
9 CH3 
H2O 543 31 605 62 0.15 1.0 
ACN 548 75 609 61 0.18 1.4 
DCM 569 67 607 38 0.70 5.4 
10 CH2CF3 
H2O 562 33 631 69 0.026 0.5 
ACN 567 43 636 69 0.12 1.2 
DCM 588 51 628 40 0.31 2.9 
R = Me 
 
R
1
 = CF3 
11 CH3 
H2O 567 13 662 95 0.019 0.3 
ACN 569 47 668 99 0.023 0.2 
DCM 600 34 657 57 0.054 0.7 
12 CH2CF3 
H2O 595 6.9 683 88 0.046 0.5 
ACN 597 26 689 92 0.12 1.4 
DCM 621 24 679 58 0.25 3.5 
 
In the case of the 4-CF3 series (11-12), F were reduced with respect the 4-CH3 analogues, even in non-
polar solvents such as DCM (e.g. 0.25 for 12 vs 0.70 for 9), which led to even lower values in polar 
solvents (e.g. 0.05 in water for 12). This is not a surprising result since the introduction of strong electron-
withdrawing groups like CF3 in coumarin or xanthene derivatives
9b,16
 is known to generate dyes with 
longer absorption and emission wavelengths, but with reduced F, a phenomenon that typically occurs 
14 
 
with NIR fluorescent dyes. Even so, the F of 11 and 12 in glycerol were considerably higher (F=0.16 
for 11 and 0.26 for 12; Table S6), which suggests that if TICT formation could be prevented this would 
further improve the F of COUPY scaffolds emitting in the far-red/NIR region.  
Finally, the photostability of 9-12 coumarins in water was studied under green LED irradiation (520 ± 18 
nm; Figure S22). Although for 12 the incorporation of the two CF3 moieties decreases it photostability, the 
other COUPY dyes (9-11) are photostable up to light fluences larger than 20 J/cm
2
, which are more than 
one order of magnitude above typical fluences used for cell imaging purposes.
2d 
To summarise, the introduction of a pyridinium moiety in COUPY scaffolds changes the accepted vision 
of the photophysics of coumarins dyes (panel A in Figure 4).
18
 Thus, in conventional coumarins, 
photoexcitation leads to a charge transfer state that is stabilized in polar solvents, leading to both red-
shifted absorption and emission. By contrast, the ground state of COUPY dyes 9-12 is slightly more polar 
than the excited state (see Table S4 and Figure S13), leading to blue-shifts in the absorption spectra. 
However, the position of the emission wavelength is essentially insensitive to the solvent polarity, 
indicating that no substantial dipole moment changes occur (panel B in Figure 4). As a result, COUPY 
dyes show larger Stokes’ shifts in polar solvents, which adds them potential value for fluorescence 
imaging applications. In both cases, formation of TICT states in polar solvents leads to faster non-
radiative decay of the excited state, which can be arrested by increasing the solvent viscosity. 
  
15 
 
 
Figure 4. Distinct solvatochromism in (A) conventional coumarins and (B) the new COUPY dyes, as 
exemplified with compounds 1 and 9. 
 
Fluorescence imaging of COUPY dyes in living cells 
Once demonstrated the promising photophysical properties of the fluorescent dyes based on COUPY 
scaffolds, we investigated their potential applications for cellular imaging. First, the cellular uptake of 
coumarin 9 was studied in HeLa cells by confocal microscopy by irradiation with a yellow light laser (ex 
= 561 nm). To our delight, fluorescence after 20 min of incubation was clearly observed in different 
cellular organelles confirming uptake by cells. At 0.5 and 1 M of coumarin 9 (Figure 5A,B respectively), 
mitochondria and intracellular vesicles were stained and also -although less intense- the nucleoli. At 2 M 
(Figure 5C) the same pattern of staining was observed but with higher fluorescence intensity. Similar 
results were obtained after incubation of HeLa cells with coumarins 10 and 11 (Figure S23), although no 
significant fluorescence was detected in nucleoli in the case of coumarin 11, which suggests a higher 
16 
 
preference for mitochondria. Interestingly the fluorescence detected in the mitochondria with coumarin 9 
disappeared shortly after continuous irradiation of the cells with the excitation laser (Figure 5D and S23) 
and left more apparent the staining of nucleoli, cytoplasm and vesicles (see below). Based on the higher 
red-shifted absorption of coumarin 12, this dye could be visualized after irradiation with red light (ex = 
633 nm), although in this case fluorescence was only detected in vesicles inside the cells (Figure S24). 
The overall results suggest that COUPY dyes have excellent cell plasma and nuclear membrane 
permeability, and that can be used for bioimaging applications in living cells at a concentration as low as 
0.5 M by incubation with a short period of time. 
 
Figure 5. Cellular uptake of coumarin 9. Single confocal planes of HeLa cells incubated with different 
concentrations of 9 for 20 min at 37ºC. A) 0.5M, B) 1 M, C and D) 2M. D) Same cells than in C) 
after 3 min of 561 nm laser irradiation. White arrows point out mitochondria, white arrowheads nucleoli 
and yellow arrowheads vesicles staining. All images are colour coded using the Fire lookup table from Fiji 
(intensity calibration bar in the upper right corner in B). Scale bar: 10 m. All images are at the same 
scale.  
17 
 
In order to confirm the subcellular localization of coumarin 9, we performed co-localization experiments 
in HeLa cells using specifics markers for mitochondria and nuclei (MitoTracker Green FM and Hoechst 
33342, respectively). As shown in Figure 6, the fluorescence emission of coumarin 9 and Mitotracker 
displayed superimposable distributions, which confirmed that COUPY dyes accumulate into the 
mitochondria. Similar results were obtained from co-localizations experiments with coumarins 10 and 11 
and MitoTracker Green FM (Figure S25). On the other hand, coumarin 9 detected inside the nuclei was 
observed where lacked Hoechst staining (Figure 6, arrowheads), thus confirming the accumulation of the 
compound inside the nucleoli as Hoechst does stain the nucleus but not the nucleolus of cells. These 
results are good agreement with previous findings on the accumulation of positively-charged fluorophores 
in these organelles, such as the dicationic bisamidine MitoBlue reported by Vázquez and Mascareñas
23
 
and other far-red/NIR emitting dyes,
5,9b,15,24
 including some pyridinium-containing compounds that 
accumulate preferably in mitochondria.
25 
Examples on the simultaneous localization of far-red/NIR 
fluorescent dyes in mitochondria and nucleoli are scarce,
15,26,27
 particularly of low-molecular weight 
organic compounds that rapidly and efficiently accumulate in nucleolus.  
We next evaluated the photostability of coumarin 9 after incubation in HeLa cells by continuous 
irradiation with the high-energy laser beam of the confocal microscope (ex= 561 nm). Besides good cell 
membrane permeability, photobleaching (the irreversible destruction of an excited dye) is another 
important parameter for imaging-related biological applications of fluorophores since it can strongly limit 
its detectability. As it was previously observed, continuous exposition of coumarin 9 to the excitation 
wavelength caused the decrease of mitochondria signal after 1-2 min (Figures S23 and S26). This intensity 
decrease however was followed by an increment of the fluorescence intensity in nucleoli and cytoplasm of 
cells (see Figures S23 and S26). It is worth noting that this process cannot be attributed to 
photodegradation of the dye since it was not accompanied by a reduction of the overall fluorescence 
signal, and suggests diffusion of the unaltered coumarin dye outside the mitochondria upon light stress, 
which then accumulates in the nucleoli and cytoplasm. By contrast, this re-distribution phenomenon was 
not observed with 10 and 11 (see Figures S23 and S26). The higher photostability of coumarins 10 and 11 
18 
 
compared with 9, particularly that of 11 (see fluorescence bleaching studies in Figure S22), indicates that 
incorporation of CF3 groups in COUPY scaffolds at the 4-position of the coumarin skeleton not only 
allows red-shifting absorption and emission but it also reduces photobleaching considerably. Finally, we 
also evaluated the retention of coumarin 9 after cell fixation using paraformaldehide (4%) and cell 
permeabilization using Triton X100. After 10 min of fixation at RT coumarin 9 was not detected in 
mitochondria although it was still observed in cytoplasm and nucleoli (Figure S27). After cell 
permeabilization, fluorescence was barely observed (Figure S27). 
 
 
Figure 6. Co-localization studies. Single confocal plane of HeLa cells incubated with coumarin 9 (0.5 
M, red), Mitotracker Green FM (0.1 M, green) and Hoechst 33342 (1 g/ml, blue). A) Overlay of the 
three staining. B), C), D) Mitotracker Green FM, Hoechst 33342 and coumarin 9, separate staining, 
respectively. White arrows point out mitochondria, white arrowheads nucleoli and yellow arrowheads 
vesicles staining. Scale bar: 10 m.  
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CONCLUSIONS 
In summary, we have developed a novel family of push-pull fluorophores based on novel coumarin 
scaffolds, nicknamed COUPY, with promising photophysical properties and great potential for cell 
imaging applications. Such coumarin scaffolds (7 and 8) were readily prepared from commercially 
available precursors (Coumarin 1 and Coumarin 152, respectively) in only two linear synthetic steps, 
being the key step the condensation of a thiocoumarin derivative with 4-pyridylacetonitrile. Subsequent N-
alkylation of the pyridine moiety allowed the rapid and efficient synthesis of a novel class of a low-
molecular weight fluorophores whose photophysical properties were tuned by selecting the appropriate 
combination of the N-alkylating group (CH3 or CH2CF3) and the substituent at position 4 (CH3 or CF3). 
Notably, COUPY dyes (9-12) show emission in the far-red/NIR region, large Stokes’ shifts in polar 
media, moderate-to-high fluorescence quantum yields, high photostability, and excellent brightness, which 
are the result of the re-ordering of the polar and non-polar electronic states as compared to conventional 
coumarins. Interestingly, NMR spectroscopy revealed the existence of rotamers in solution, and these 
experimental observations were supported by computational studies. Owing to their low molecular weight, 
COUPY dyes show excellent cell permeability and accumulate selectively in nucleoli and/or mitochondria 
of HeLa cells, being their far red/NIR fluorescence emission easily detected at a concentration as low as 
0.5 M. 
Taking into account the promising photophysical properties and excellent cell permeability of the 
fluorophores described in this work, we anticipate that COUPY scaffolds could be used as a basis to 
synthesize novel NIR-emitting probes with wide biological applications including organelle imaging, 
biomolecule labelling, cancer imaging and fluorescence-guided surgery. Work is in progress in our 
laboratory to increase the red-shifted properties of COUPY scaffolds with the aim of shifting absorption 
and emission into the NIR as well as for improving brightness in aqueous media. This work will be 
reported in due course.  
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EXPERIMENTAL SECTION 
Materials and Methods 
Unless otherwise stated, common chemicals and solvents (HPLC grade or reagent grade quality) were 
purchased from commercial sources and used without further purification. Aluminium plates coated with a 
0.2 mm thick layer of silica gel 60 F254 were used for thin-layer chromatography analyses (TLC), whereas 
flash column chromatography purification was carried out using silica gel 60 (230-400 mesh). Reversed-
phase high-performance liquid chromatography (HPLC) analyses were carried out on a Jupiter Proteo C18 
column (250x4.6 mm, 90 Å 4 m, flow rate: 1 mL/min) using linear gradients of 0.045% TFA or 0.1% 
formic acid in H2O (A) and 0.036% TFA or 0.1% formic acid in ACN (B). NMR spectra were recorded at 
25 
o
C in a 400 MHz spectrometer using the deuterated solvent as an internal deuterium lock. 
Tetramethylsilane (TMS) was used as an internal reference (0 ppm) for 
1
H spectra recorded in CDCl3 and 
the residual protic signal of the solvent (77.16 ppm) for 
13
C spectra. The residual protic signal of methanol 
and DMSO was used as a reference in 
1
H and 
13
C NMR spectra recorded in CD3OD and DMSO-d6, 
respectively. Chemical shifts are reported in part per million (ppm) in the  scale, coupling constants in Hz 
and multiplicity as follows: s (singlet), d (doublet), t (triplet), q (quartet), qt (quintuplet), m (multiplet), dd 
(doublet of doublets), dt (doublet of triplets), ddd (doublet of doublet of doublets), br (broad signal), etc. 
The proton signals of the E and Z rotamers were identified by simple inspection of the 
1
H spectrum and 
the rotamer ratio was calculated by peak integration. 2D-NOESY spectra were acquired in DMSO-d6 with 
mixing times of 300 and 500 ms. The 1D gradient NOE spectra were obtained in a 400 MHz spectrometer 
using a Gaussian selective pulse and a 0.5 s mixing time with a standard 1D gradient NOE pulse sequence. 
Electrospray ionization mass spectra (ESI-MS) were recorded on an instrument equipped with single 
quadrupole detector coupled to an HPLC, high-resolution (HR) ESI-MS on a LC/MS-TOF instrument.  
Synthesis and characterization of (coumarin-4-yl)methyl derivatives (7, 9-10).  
2-(Cyano(4-pyridine)methylene)-7-(N,N-diethylamino)-4-methyl-coumarin (7). Compound 2
13
 (1 g, 4.04 
mmol) was added to a solution of 4-pyridylacetonitrile hydrochloride (1.25 mg, 8.12 mmol) and NaH 
(60% dispersion in mineral oil, 2.4 g, 60 mmol) in dry ACN (20 mL) under an Ar atmosphere and 
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protected from light. After stirring for 2 h at room temperature, silver nitrate (1.45 g, 8.22 mmol) was 
added and the reaction mixture was stirred at room temperature for 2 h under an Ar atmosphere and 
protected from light. The crude product was evaporated under reduced pressure and purified by column 
chromatography (silica gel,0-2% MeOH in DCM) to give 1.19 g of red solid (yield 89%). mp 173-175 
o
C; 
TLC: Rf (10% MeOH in DCM) 0.65. 
1
H NMR (400 MHz, CDCl3 δ (ppm): (major rotamer) 8.57 (2H, d, 
py, J = 6.4 Hz), 7.72 (2H, d, py, J = 6.4 Hz), 7.32 (1H, d, H5, J = 9.2 Hz), 6.73 (1H, br q, H3, J = 0.8 Hz), 
6.58 (1H, dd, H6, J = 9.2 Hz, J = 2.4 Hz), 6.44 (1H, d, H8, J=2.4 Hz), 3.45 (4H, q, CH2 Et, J = 7.2 Hz), 
2.33 (3H, d, CH3, J = 0.8 Hz), 1.24 (6H, t, CH3 Et, J = 7.2 Hz). 
13
C NMR (101 Hz, CDCl3) δ (ppm): 
(major rotamer) 163.5, 154.4, 150.6, 150.1, 149.8, 144.0, 141.0, 125.4, 120.7, 119.9, 112.3, 109.9, 109.1, 
96.9, 81.3, 44.7, 18.4, 12.5. HR-ESI MS, positive mode: m/z 332.1761 (calcd mass for C21H22N3O 
[M+H]
+
: 332.1757). Analytical HPLC (30 to 100% B in 30 min, TFA additive: Rt = 13.5 min). 
2-(Cyano((1-methyl(4-pyridin-1-ium)))methylene)-7-(N,N-diethylamino)-4-methyl-coumarin triflate (9). 
Methyl trifluoromethanesulfonate (48 µL, 0.42 mmol) was added to a solution of 7 (70 mg, 0.21 mmol) in 
DCM (30 mL). The mixture was stirred overnight at room temperature under an Ar atmosphere and 
protected from light. After removal of the major part of the solvent, the triflate salt was precipitated with 
diethyl ether. The product was centrifuged and washed with diethyl ether and vacuum dried to give 96 mg 
of purple solid (yield 93%). TLC: Rf (DCM) 0.53. 
1
H NMR (400 MHz, CD3OD) δ (ppm): (major rotamer) 
8.45 (2H, d, py, J = 7.4 Hz), 8.21 (2H, d, py, J = 7.4 Hz), 7.73 (1H, d, H5, J = 9.2 Hz), 7.02-6.96 (3H, m, 
H3+H6+H8), 4.20 (3H, s, CH3-py), 3.61 (4H, q, CH2 Et, J = 7.2 Hz), 2.56 (3H, s, CH3), 1.29 (6H, t, CH3 
Et, J = 7.2 Hz). 
19
F NMR (376,5 MHz, CD3OD): -80.2 (3F, s, Tf). 
13
C NMR (101 Hz, DMSO-d6) δ (ppm): 
(major rotamer) 166.6, 154.7, 152.3, 151.9, 148.5, 143.8, 127.0, 120.7 (q, J = 323 Hz, Tf), 120.6, 118.3, 
111.7, 110.4, 110.2, 96.4, 77.9, 46.0, 44.2, 18.4, 12.4. HR-ESI MS, positive mode: m/z 346.1912 (calcd 
mass for C22H24N3O [M]
+
: 346.1919). Analytical HPLC (30 to 100% B in 30 min, TFA additive: Rt = 13.5 
min). 
2-(Cyano((1-(2,2,2-trifluoroethyl)(4-pyridin-1-ium)))methylene)-7-(N,N-diethylamino)-4-methyl-coumarin 
triflate (10). 2,2,2-Trifluoroethyl trifluoromethanesulfonate (80 µL, 0.54 mmol) was added to a solution of 
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7 (30 mg, 0.09 mmol) in dry ACN (20 mL). The mixture was stirred at 70 
o
C during 24 h under an Ar 
atmosphere and protected from light. Then, most of the solvent was evaporated and the triflate salt of the 
compound was precipitated with diethyl ether. The product was centrifuged and washed with diethyl ether 
and vacuum dried to give 40 mg of purple solid (yield 78%). TLC: Rf (DCM) 0.53. 
1
H NMR (400 MHz, 
CD3OD) δ (ppm): (major rotamer) 8.47 (2H, d, py, J = 7.0 Hz), 8.22 (2H, d, py, J = 7.0 Hz), 7.78 (1H, d, 
H5, J=8.8 Hz), 7.08-7.04 (3H, m, H3+H6+H8), 5.32 (2H, q, CH2-CF3, J = 8.4 Hz), 3.54 (4H, q, CH2 Et, J 
= 7.2 Hz), 2.63 (3H, s, CH3), 1.31 (6H, t, CH3 Et, J = 7.2 Hz).
 19
F NMR (376,5 MHz, CD3OD): -73.2 (3F, 
t, CF3-CH2, J = 8.4 Hz), -80.1 (3F, s, Tf). 
13
C NMR (101 Hz, DMSO-d6) δ (ppm): (major rotamer) 167.2, 
155.2, 154.5, 152.4, 150.7, 143.6, 127.3, 123.1 (q, J = 280 Hz), 120.7 (q, J = 323 Hz, Tf), 120.3, 118.0, 
112.6, 110.9, 110.6, 96.3, 78.6, 56.4 (q, J = 34 Hz), 44.3, 18.5, 12.4. HR-ESI MS, positive mode: m/z 
414.1788 (calcd mass for C23H23F3N3O [M]
+
: 414.1793). Analytical HPLC (30 to 100% B in 30 min, TFA 
additive: Rt = 16.1 min). 
Synthesis and characterization of (coumarin-4-yl)trifluoromethyl derivatives (6, 8, 11-12).  
7-(N,N-Dimethylamino)-4-trifluoromethyl-2-thiocoumarin (6). 7-(N,N-Diethylamino)-4-
(trifluoromethyl)coumarin (3 g, 11.66 mmol) and Lawesson’s reagent (2.65 g, 6.55 mmol) were dissolved 
in toluene (70 mL) and heated at 100 
o
C for 15 h. After evaporation under reduced pressure, the red 
residue was purified by column chromatography (silica gel, 0-50% DCM in Hexane) to give 2.91 g of a 
red solid (yield 91 %). mp 169-171 
o
C; TLC: Rf (DCM) 0.50. 
1
H NMR (400 MHz, CDCl3) δ (ppm): 7.53 
(1H, dq, J = 9.0 Hz, J = 2 Hz), 7.17 (1H, s), 6.70 (1H, dd, J = 9.0, J = 2.8 Hz), 6.68 (1H, d, J = 2.4 Hz), 
3.10 (6H, s). 
19
F NMR (376,5 MHz, CDCl3): -63.74 (3F, d, CF3, J = 2 Hz). 
13
C NMR (101 Hz, CDCl3) δ 
(ppm): 196.0, 159.5, 153.3, 133.0 (q, J = 32 Hz), 125.8 (q, J = 3 Hz), 122.4 (q, J = 275 Hz), 121.0 (q, J = 
6 Hz), 110.8, 105.2, 97.9, 40.1. HR-ESI MS, positive mode: m/z 274.0508 (calcd mass for C12H11F3NOS 
[M+H]
+
: 274.0508). 
2-(Cyano(4-pyridine)methylene)-7-(N,N-dimethylamino)-4-trifluoromethyl-coumarin (8). Compound 6 
(700 mg, 2.56 mmol) was added to a solution of 4-pyridylacetonitrile hydrochloride (607 mg, 3.94 mmol) 
and NaH (60% dispersion in mineral oil, 1.5 g, 37.5 mmol) in dry ACN (25 mL) under an Ar atmosphere 
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and protected from light. After stirring for 2 h at room temperature, silver nitrate (956 mg, 5.63 mmol) 
was added and the reaction mixture was stirred at room temperature for 2 h under an Ar atmosphere and 
protected from light. The crude product was evaporated under reduced pressure and purified by column 
chromatography (silica gel, 0-2% MeOH in DCM) to give 765 mg of red solid (yield 84%). TLC: Rf 
(DCM) 0.53. 
1
H NMR (400 MHz, CDCl3 δ (ppm): (major rotamer) 8.66 (2H, m, py), 7.74 (2H, m, py), 
7.43 (1H, dq, H5, J = 9.2 Hz, J = 2 Hz), 7.16 (1H, s, H3), 6.61 (1H, dd, H6, J = 9.2 Hz, J = 2.4 Hz), 6.47 
(1H, d, H8, J = 2.4 Hz), 3.12 (6H, s, CH3). 
19
F NMR (376,5 MHz, CD3OD): -64.2 (3F, br s, CF3). 
13
C 
NMR (101 Hz, CDCl3) δ (ppm): (major rotamer) 160.5, 154.8, 153.3, 150.3, 139.5, 132.8 (q, J = 32 Hz), 
126.1, 122.2 (q, J = 275 Hz), 121.4, 118.2, 112.6 (q, J = 6 Hz), 109.9, 103.8, 97.9, 88.4, 40.4. HR-ESI 
MS, positive mode: m/z 358.1155 (calcd mass for C19H15F3N3O [M+H]
+
: 358.1162). Analytical HPLC (30 
to 100% B in 30 min, TFA additive: Rt = 13.4 min). 
2-(Cyano((1-methyl(4-pyridin-1-ium)))methylene)-7-(N,N-dimethylamino)-4-trifluoromethyl-coumarin 
triflate (11). Methyl trifluoromethanesulfonate (19 µL, 0.17 mmol) was added to a solution of 8 (30 mg, 
0.08 mmol) in DCM (20 mL), and the mixture was stirred at room temperature overnight under an Ar 
atmosphere and protected from light. Then, most of the solvent was removed and the triflate salt of the 
compound was precipitated with diethyl ether. The product was centrifuged and washed with diethyl ether 
and vacuum dried to give 36 mg of a purple solid (yield 76%). TLC: Rf (DCM) 0.53. 
1
H NMR (400 MHz, 
DMSO-d6) δ (ppm): (major rotamer) 8.76 (2H, d, py, J = 7.2 Hz), 8.32 (2H, d, py, J = 7.2 Hz), 7.54 (1H, 
dq, H5, J = 9.2 Hz, J = 2 Hz), 7.10 (1H, d, H8, J = 2.4 Hz), 7.06 (1H, s, H3), 7.00 (1H, dd, H6, J = 9.2 Hz, 
J = 2.4 Hz), 4.28 (3H, s, CH3-py), 3.17 (6H, s, CH3).
 19
F NMR (376,5 Mz, CD3OD): -65.22 (3F, d, CF3, J 
= 2 Hz), -80.16 (3F, s, Tf). 
13
C NMR (101 Hz, DMSO-d6) δ (ppm): (major rotamer; the trifluoroacetate 
salt of the compound was used for recording 
13
C NMR spectrum) 164.6, 158.0 (q, J = 34 Hz, TFA), 155.0, 
154.0, 146.9, 144.8, 134.6 (q, J = 32 Hz), 125.5, 122.6, 121.8 (q, J = 276 Hz), 117.1, 116.2 (q, J = 296 Hz, 
TFA), 112.1, 109.8 (q, J = 5.8 Hz), 103.3, 98.0, 84.3, 46.8. HR-ESI MS, positive mode: m/z 372.1315 
(calcd mass for C20H17F3N3O [M]
+
: 372.1323). Analytical HPLC (30 to 100% B in 30 min, TFA additive: 
Rt = 13.1 min). 
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2-(Cyano((1-(2,2,2-trifluoroethyl)(4-pyridin-1-ium)))methylene)-7-(N,N-dimethylamino)-4-
trifluoromethyl-coumarin triflate (12). 2,2,2-Trifluoroethyl trifluoromethanesulfonate (122 µL, 0.84 
mmol) was added to a solution of 8 (50 mg, 0.14 mmol) in dry ACN (20 mL). The mixture was stirred at 
70ºC during 24 h under an Ar atmosphere and protected from light. The crude product was evaporated 
under reduced pressure and purified by column chromatography (silica gel,0-10% MeOH in DCM) to give 
38 mg of dark blue solid (yield 46%). TLC: Rf (DCM) 0.53. 
1
H NMR (400 MHz, CD3OD) δ (ppm): (major 
rotamer) 8.74 (2H, d, py, J = 7.0 Hz), 8.47 (2H, d, py, J = 7.0 Hz), 7.69 (1H, dq br, H5, J = 9.2 Hz), 7.28 
(1H, s, H3), 7.16 (1H, d, H8, J = 2.4 Hz), 7.09 (1H, dd, H6, J = 9.2 Hz, J=2.4 Hz), 5.49 (2H, m, CH2-
CF3,), 3.25 (6H, s, CH3).
 19
F NMR (376.5 Hz, CD3OD): -64.98 (3F, s, CF3), -73.05 (3F, t, CH2-CF3, J = 
8.3 Hz), -80.16 (3F, s, Tf).
13
C NMR (101 Hz, DMSO-d6) δ (ppm): (major rotamer) 166.0, 155.4, 154.3, 
149.6, 144.9, 135.7 (q, J = 32 Hz), 125.7, 122.9 (q, J = 280 Hz), 122.6, 121.8 (q, J = 277 Hz), 120.7 (q, J 
= 323 Hz, Tf), 117.0, 113.0, 109.3, 104.0, 98.0, 84.2, 56.9 (q, J = 34 Hz), 39.8. HR-ESI MS, positive 
mode: m/z 440.1190 (calcd mass for C21H16F6N3O [M]
+
: 440.1192). Analytical HPLC (30 to 100% B in 30 
min, TFA additive: Rt = 15.3 min). 
Photophysical characterization of coumarin derivatives 9-12 
For the photophysical measurements, all solvents used were spectroscopic grade. Absorption spectra were 
recorded in a Varian Cary 6000i spectrophotometer (Varian, Palo Alto, CA, USA) at room temperature. 
Molar absorption coefficients () were determined by direct application of the Beer-Lambert law, using 
solutions of 9-12 in each solvent with concentrations ranging from 10
−6
 to 10
−5
 M. Emission spectra were 
registered in a Fluoromax-4 spectrofluorometer (Horiba Jobin-Ybon, Edison, NJ, USA).  
Fluorescence quantum yields (ΦF) were measured by comparative method using cresyl violet in ethanol 
(CV; F;Ref = 0.54 ± 0.03) as reference.
28
 Then, optically-matched solutions of 9-12 and CV were excited 
and the fluorescence spectra was recorded. The absorbance of sample and reference solutions was set 
below 0.1 at the excitation wavelength and F were calculated using the following equation (1): 
ф𝐹;𝑆𝑎𝑚𝑝𝑙𝑒 =
𝐴𝑟𝑒𝑎𝑆𝑎𝑚𝑝𝑙𝑒
𝐴𝑟𝑒𝑎𝑅𝑒𝑓
𝑥 (
ƞ𝑆𝑎𝑚𝑝𝑙𝑒
ƞ𝑅𝑒𝑓
)
2
𝑥 ф𝐹;𝑟𝑒𝑓  (1) 
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where AreaSample and AreaRef are the integrated fluorescence for the sample and the reference and ƞSample 
and ƞRef are the refractive index of sample and reference solutions respectively. 
Time-resolved fluorescence decays were registered with a time-correlated single photon counting system 
(Fluotime 200, PicoQuant GmbH, Berlin, Germany). The samples were excited at 504 nm by means of a 
picosecond-pulsed LED working at 10 MHz repetition rate. Fluorescence decays were acquired at the 
emission maxima and they were analyzed using the PicoQuant FluoFit c4.6.5 data analysis software. The 
counting frequency was kept always below 1%. 
The dipoles moments () differences between the ground (g) and excited states (e) for 9-12 have been 
estimated from the Lippert-Mataga equation (eq. 2):
29 
𝑆𝑡𝑜𝑘𝑒𝑠 𝑠ℎ𝑖𝑓𝑡 = ?̅?𝑎 − ?̅?𝑓 =  
2
ℎ𝑐𝑎03
 𝑥 (
𝜀 − 1
2𝜖 + 1
−
𝑛2 − 1
2𝑛2 + 1
)  𝑥 (𝜇𝑒 − 𝜇𝑔)
2
=
2
ℎ𝑐𝑎03
 𝑥 ∆𝑓 𝑥 ∆𝜇2     (2) 
where h is Plank’s constant, c is the velocity of light, a0 is the radius of the Onsager cavity around the 
fluorophore. The parameters  and n are the solvent dielectric constant and refractive index, respectively, 
which are grouped in the term f. The Onsager radius was taken as half of the average distance between 
the push-pull moieties of the COUPYs fluorophores as described by Mukherjee et al.
30 
Photostability studies were performed by monitoring fluorescence bleaching of a 5 M 9-12 aqueous 
solution irradiated with green LED light (520 ± 18 nm; 6.7 mWcm
-2
; LED Par 64 Short V2 lamp 
(Showtec, Kerkrade, Netherlands)). 
Cell culture and treatments 
HeLa Cells were maintained in DMEM (Dullbecco Modified Eagle Medium) containing low glucose (1 
g/L) and supplemented with 10% foetal calf serum (FCS), 50U/mL penicillin-streptomycin and 2 mM L-
glutamine (everything from Biological Industries). For cellular uptake experiments and posterior 
observation under the microscope, cells were seeded on glass bottom dishes (P35G-1.5-14-C, Mattek). 24 
h after cell seeding, cells were incubated for 20 or 30 min at 37ºC with the required concentration of 
coumarins 9-12 in supplemented DMEM. Then, cells were washed three times with DPBS (Dulbecco's 
Phosphate-Buffered Saline, Gibco) to remove the excess of the compounds and kept in low glucose 
26 
 
DMEM without phenol red (Gibco) for fluorescence imaging. Unless otherwise stated, no fixation was 
carried out.  
For co-localization experiments, HeLa cells were treated with 9 (0.5 M) and MitoTracker Green FM (0.1 
M, Life Technologies) for 30 min at 37ºC in non-supplemented DMEM. After removal of the medium 
and washing three times with DPBS, cells were incubated for 10 min at 37ºC with Hoechst 33342 (1 
g/ml, Life Technologies) in supplemented DMEM. Finally, cells were washed and kept in low glucose 
DMEM without phenol red (Gibco) for fluorescence imaging. Co-localization experiments with 10 and 11 
were carried out with a higher concentration of dye (2 M). Quantitative analysis of the co-localization of 
coumarins 9-11 and MTG resulted in Pearson’s correlation coefficients in the order of 0.73-0.80 
(SD<0.09). 
For fixation studies, HeLa cells were treated with 9 (1 M) for 30 min at 37ºC. After removal of the 
medium and washing three times with DPBS, cells were fixed with 4% Paraformaldehyde (Sigma) in PBS 
for 15 min at room temperature. Then cells were washed again and kept in DPBS for their observation 
under the microscope. Finally, cells were washed and treated with Triton X100 0.5% in PBS for 10 min at 
room temperature. Cells were washed and kept again in PBS for their observation under the microscope.  
For photostability studies, HeLa cells were incubated with the compounds (2 M, 30 min at 37ºC) and 
kept in low glucose DMEM without phenol red (Gibco) for fluorescence imaging. 
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